chronic insomnia epidemiology forecast insight

DelveInsight’s ‘Chronic Insomnia – Epidemiology Forecast—2034’ report delivers an in-depth understanding of Chronic Insomnia, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan

Geographies Covered

The United States
EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Japan

Study Period: 2021-2034

Chronic Insomnia Disease Understanding

Insomnia is the most common sleep disorder in the world that carries a huge socio-economic cost. According to the third edition of the Classification of Sleep Disorders (ICSD-3), insomnia is characterized by difficulty in either initiating sleep, maintaining sleep continuity, or poor sleep quality. For chronic insomnia, sleep disturbances occur at least three times a week and have been present for the last 3 months.

Individuals who have difficulty coping with a stressful situation or report being habitual light sleepers have an elevated propensity to develop chronic insomnia. There is a high rate of association between insomnia and psychiatric disorders like depression, anxiety, and post-traumatic stress disorder. Comorbid medical issues like restless legs syndrome, chronic pain, gastroesophageal reflux disease (GERD), respiratory issues, and immobility are associated with the risk of chronic insomnia.

Chronic insomnia represents a more complex condition than acute transient insomnia. Patients with chronic insomnia usually have accompanying daytime impairment of cognition, mood, or performance that impacts the patient and his family and affects friends, coworkers, and caretakers. Insomnia patients are more likely to visit hospitals and physicians, have increased absenteeism, make errors or have accidents at work, and have more fatal road accidentsThere is also an increased risk for depression, anxiety, substance-use, suicide, and possibly immune dysfunction.

Chronic Insomnia Epidemiology

The Chronic Insomnia epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends, along with assumptions undertaken.

Key Findings

The total prevalent cases of Chronic Insomnia patients are increasing in 7MM during the study period, i.e., 2021-2034. The disease epidemiology covered in the report provides historical as well as forecasted Chronic Insomnia symptoms epidemiology segmented as the Prevalence of Insomnia, Diagnosed Prevalent Cases of Chronic Insomnia, Gender-specific cases of Chronic Insomnia, and Age-specific cases of Chronic Insomnia. The report includes the prevalent scenario of Chronic Insomnia symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country-wise - Chronic Insomnia Epidemiology

The epidemiology segment also provides the Chronic Insomnia epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The diagnosed prevalent cases of Chronic Insomnia associated in 7MM countries were 5,585,128 in 2020.

As per the estimates, the United States has the largest prevalent population of Chronic Insomnia.
Among the EU5 countries, France had the highest prevalent cases of Chronic Insomnia, followed by Germany. On the other hand, Spain had the lowest prevalent cases with 273,947 cases in 2020.

Scope of the Report

The Chronic Insomnia report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
The Chronic Insomnia Epidemiology Report and Model provide an overview of Chronic Insomnia's risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
The report provides insight into Chronic Insomnia's historical and forecasted patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
The report assesses the disease risk and burden and highlights the unmet needs of Chronic Insomnia.
The report provides the segmentation of the Chronic Insomnia epidemiology by prevalent cases of Insomnia in 7MM.
The report provides the Chronic Insomnia epidemiology segmentation by diagnosed prevalent cases of Chronic Insomnia in 7MM.
The report provides the Chronic Insomnia epidemiology segmentation by Gender-specific prevalent cases of Chronic Insomnia in 7MM.
The report provides the Chronic Insomnia epidemiology segmentation by Age-specific prevalent cases of Chronic Insomnia in 7MM.

Report Highlights

10-year Forecast of Chronic Insomnia epidemiology
7MM Coverage
Prevalent Cases of Insomnia
Total Diagnosed Prevalent Cases of Chronic Insomnia
Prevalent Cases according to segmentation: Gender-specific cases of Chronic Insomnia
Prevalent Cases according to segmentation: Age-specific cases of Chronic Insomnia

KOL Views

We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

What will be the growth opportunities in the 7MM for the patient population about Chronic Insomnia?
What are the key findings of the Chronic Insomnia epidemiology across 7MM, and which country will have the highest number of patients during the study period (2021-2034)?
What would be the total number of Chronic Insomnia patients across the 7MM during the study period (2021-2034)?
Among the EU5 countries, which country will have the highest number of patients during the study period (2021-2034)?
At what CAGR the patient population is expected to grow in 7MM during the study period (2021-2034)?
What are the disease risk, burden, and unmet needs of Chronic Insomnia?
What are the currently available treatments for Chronic Insomnia?

Reasons to buy

The Chronic Insomnia epidemiology report will allow the user to -

Develop business strategies by understanding the trends shaping and driving the global Chronic Insomnia market.
Quantify patient populations in the global Chronic Insomnia market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Chronic Insomnia therapeutics in each of the markets covered.
Understand the magnitude of the Insomnia population by its Total Prevalent cases.
Understand the magnitude of the Chronic Insomnia population by its Total Diagnosed Prevalent cases.
Understand the magnitude of the Chronic Insomnia population by its Gender-specific cases.
Understand the magnitude of the Chronic Insomnia population by its Age-specific cases.
The Chronic Insomnia epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
The Chronic Insomnia Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over an 10-year forecast period using reputable sources.

Key Assessments

Patient Segmentation
Disease Risk and Burden
Risk of disease by the segmentation
Factors driving growth in a specific patient population